Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev Am Soc Microbiol. 1998;11:57–80.
Article
CAS
Google Scholar
Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev Am Soc Microbiol. 2012;25:2–41.
Article
CAS
Google Scholar
Looney WJ, Narita M, Mühlemann K. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis. 2009;9:312–23.
Article
CAS
Google Scholar
Correia CR, Ferreira ST, Nunes P. Stenotrophomonas maltophilia: rare cause of meningitis. Pediatr Int . 2014;56:e21–2.
Article
Google Scholar
Burns RL, Lowe L. Xanthomonas maltophilia infection presenting as erythematous nodules. J Am Acad Dermatol . 1997;37:836–8.
Article
CAS
Google Scholar
Subhani S, Patnaik AN, Barik R, Nemani L. Infective endocarditis caused by Stenotrophomonas maltophilia: a report of two cases and review of literature. Indian Heart J. 2016;68:S267–70.
Article
Google Scholar
Sattler CA, Mason EO Jr, Kaplan SL. Nonrespiratory Stenotrophomonas maltophilia infection at a children’s hospital. Clin Infect Dis. 2000;31:1321–30.
Article
CAS
Google Scholar
Micozzi A, Venditti M, Monaco M, Friedrich A, Taglietti F, Santilli S, et al. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis. 2000;31:705–11.
Article
CAS
Google Scholar
Biagi M, Tan X, Wu T, Jurkovic M, Vialichka A, Meyer K, et al. Activity of potential alternative treatment agents for Stenotrophomonas maltophilia isolates nonsusceptible to levofloxacin and/or trimethoprim-sulfamethoxazole. J Clin Microbiol. 2020;58:e01603-19.
Article
Google Scholar
Gajdács M, Urbán E. Prevalence and antibiotic resistance of Stenotrophomonas maltophilia in respiratory tract samples: a 10-year epidemiological snapshot. Heal Serv Res Manag Epidemiol. 2019;6:2333392819870774.
Google Scholar
Juhász E, Pongrácz J, Iván M, Kristóf K. Antibiotic susceptibility of sulfamethoxazole-trimethoprim resistant Stenotrophomonas maltophilia strains isolated at a tertiary care centre in Hungary. Acta Microbiol Immunol Hung Akadémiai Kiadó. 2015;62:295–305.
Article
Google Scholar
Jeon YD, Jeong WY, Kim MH, Jung IY, Ahn MY, Ann HW, et al. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia. Medicine. 2016;95:e4375.
Article
Google Scholar
Alqahtani JM. Emergence of Stenotrophomonas maltophilia nosocomial isolates in a Saudi children’s hospital: risk factors and clinical characteristics. Saudi Med J. 2017;38:521–7.
Article
Google Scholar
Naeem T, Absar M, Somily AM. Antibiotic resistance among clinical isolates of Stenotrophomonas maltophilia at a teaching hospital in Riyadh, Saudi Arabia. J Ayub Med Coll Abbottabad Pakistan. 2012;24:30–3.
Google Scholar
Tomlinson D, Mermel LA, Ethier M-C, Matlow A, Gillmeister B, Sung L. Defining bloodstream infections related to central venous catheters in patients with cancer: a systematic review. Clin Infect Dis. 2011;53:697–710. https://0-doi-org.brum.beds.ac.uk/10.1093/cid/cir523.
Article
PubMed
Google Scholar
Velázquez-Acosta C, Zarco-Márquez S, Jiménez-Andrade MC, Volkow-Fernández P, Cornejo-Juárez P. Stenotrophomonas maltophilia bacteremia and pneumonia at a tertiary-care oncology center: a review of 16 years. Support Care Cancer. 2018;26:1953–60.
Article
Google Scholar
Zhang Y, Du M, Johnston JM, Andres EB, Suo J, Yao H, et al. Estimating length of stay and inpatient charges attributable to hospital-acquired bloodstream infections. Antimicrob Resist Infect Control. 2020;9:137.
Article
Google Scholar
Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med USA. 2002;137:791–7.
Article
Google Scholar
Haque M, Sartelli M, McKimm J, Abu BM. Health care-associated infections—an overview. Infect Drug Resist. 2018;11:2321–33.
Article
Google Scholar
Pittet D, Wenzel RP. Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med. 1995;155:1177–84.
Article
CAS
Google Scholar
Institute C and LS. Performance standards for antimicrobial susceptibility testing. CLSI Suppl. M100. Clinical and Laboratory Standards Institute Wayne, PA; 2017.
Wu PS, Lu CY, Chang LY, Hsueh PR, Lee PI, Chen JM, et al. Stenotrophomonas maltophilia bacteremia in pediatric patients—a 10-year analysis. J Microbiol Immunol Infect. 2006;39:144–9.
PubMed
Google Scholar
Güriz H, Çiftçi E, Ayberkin E, Aysev D, Ince E, Arsan S, et al. Stenotrophomonas maltophilia bacteraemia in Turkish children. Ann Trop Paediatr. 2008;28:129–36.
Article
Google Scholar
Tokatly Latzer I, Paret G, Rubinstein M, Keller N, Barkai G, Pessach IM. Management of Stenotrophomonas maltophilia infections in critically ill children. Pediatr Infect Dis J. 2018;37:981–6.
Article
Google Scholar
Sumida K, Chong Y, Miyake N, Akahoshi T, Yasuda M, Shimono N, et al. Risk factors associated with Stenotrophomonas maltophilia bacteremia: a matched case-control study. PLoS ONE. 2015;10:e0133731–e0133731.
Article
Google Scholar
Cai B, Tillotson G, Benjumea D, Callahan P, Echols R. The Burden of bloodstream infections due to Stenotrophomonas maltophilia in the United States: a large, retrospective database study. Open Forum Infect Dis. 2020. https://0-doi-org.brum.beds.ac.uk/10.1093/ofid/ofaa141.
Article
PubMed
PubMed Central
Google Scholar
Chang YT, Lin CY, Chen YH, Hsueh PR. Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options. Front Microbiol. 2015;6:1–20.
Google Scholar
Sader HS, Jones RN, Stilwell MG, Dowzicky MJ, Fritsche TR. Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents. Diagn Microbiol Infect Dis . 2005;52:181–6.
Article
CAS
Google Scholar
Wang YL, Scipione MR, Dubrovskaya Y, Papadopoulos J. Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections. Antimicrob Agents Chemother. 2014;58:176–82.
Article
Google Scholar
Gales AC, Seifert H, Gur D, Castanheira M, Jones RN, Sader HS. Antimicrobial susceptibility of Acinetobacter calcoaceticus-Acinetobacter baumannii complex and Stenotrophomonas maltophilia clinical isolates: results from the SENTRY antimicrobial surveillance program (1997–2016). Open forum Infect Dis. 2019;6:S34-46.
Article
Google Scholar
Arthur C, Tang X, Romero JR, Gossett JG, Harik N, Prodhan P. Stenotrophomonas maltophilia infection among young children in a cardiac intensive care unit: a single institution experience. Pediatr Cardiol . 2015;36:509–15.
Article
Google Scholar
Wisplinghoff H. Pseudomonas spp., Acinetobacter spp. and miscellaneous gram-negative bacilli. Infect Dis (Auckl). 2017. https://0-doi-org.brum.beds.ac.uk/10.1016/B978-0-323-04579-7.00170-2.
Article
Google Scholar
Senol E, DesJardin J, Stark PC, Barefoot L, Snydman DR. Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin Infect Dis. 2002;34:1653–6.
Article
Google Scholar